Theramed Corporation

Theramed actively partners with pharmaceutical / biotechnology companies both within Canada and from around the globe to represent and promote their products within Canada.

International Partners
For international partners Theramed becomes their 'Team Canada', navigating the Canadian healthcare system on their behalf and managing all commercial and regulatory aspects of their products.

Canadian Partners
For our Canadian partners, Theramed stewards and promotes their brands, ensuring maximum reach, frequency and impact amongst target physician groups.

Below is a partial listing of partner relationships:

AstraZeneca is a global pharmaceutical firm treat disorders in the gastrointestinal, cardiac and vascular, neurological and psychiatric, infection, respiratory, pathological inflammation and oncology areas. In a recently concluded partnership Theramed performed all marketing and sales activities for Plendil^®, Rhinocort^® and Zestril^® in Canada. (Case study available ).

Baxter is a leading manufacturer of biopharmaceutical products to treat hemophilia, immune disorders, alpha 1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Theramed is proud to be the Canadian commercialization partner for Baxter, presently introducing FSME-IMMUN^®, the ONLY vaccine for Tick Borne Encephalitis (TBE) licensed and available in Canada.

EUSA Pharma is a specialty pharmaceutical company with a strong and growing portfolio of specialized hospital medicines focused on oncology, pain control and critical care, which it markets predominantly in Europe and the US (as the company’s name suggests). Theramed is EUSA Pharma’s Canadian commercialization partner, and is presently introducing CollatampG^®, an important new paradigm for the prevention and treatment of surgical site infections, to Canadian hospitals.

EMS Sigma Pharma is Brazil's leading pharmaceutical company. Theramed is their Canadian market representative with first right of refusal for Canadian commercialization of their product portfolio.

Genzyme Corporation is a global biopharmaceutical firm with products for lysosomal storage diseases, renal disease, orthopedics, transplant and immune diseases, oncology, genetics and diagnostics. In a recently concluded partnership, Theramed marketed Thyrogen^® and Thymoglobulin^® in Canada. (Case study available ).

Glenveigh Medical is a life science and medical technology company focused on advancing the practice of obstetrics, with aspirations to rapidly become the market leader in the OB/GYN field. Formed in 2004 by a maternal-fetal medicine (MFM) specialist, Glenveigh is founded on the core mission of improving the lives of pregnant mothers and their babies.

Shire plc is a global biopharmaceutical firm with products in psychiatric, gastrointestinal (GI), human genetic therapies (HGT), and renal diseases. In a recently concluded partnership, Theramed performed Specialty and Primary Care sales for Estrace^®. (Case study available ).

Triton Pharma is a specialty pharmaceutical firm with a focus on women’s health. In a recently concluded partnership Theramed performed Specialty and Primary Care Sales for Triton’s flagship product for treatment of menopausal symptoms, Bellergal^® SpaceTabs^®. (Case study available ).